ForDyne B.V. 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-17 4:00 pm Sale | 2024-12-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS | ForDyne B.V. | 11,123,614 10.400% | -696,949 (-5.90%) | Filing |
| 2024-11-15 4:29 pm Sale | 2024-11-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS | ForDyne B.V. | 11,820,563 12.800% | -10,898 (-0.09%) | Filing |
| 2023-07-07 5:06 pm Purchase | 2023-06-05 | 13D | NewAmsterdam Pharma Company N.V. NAMS | ForDyne B.V. | 11,831,461 14.500% | 3,589,061 (+43.54%) | Filing |
| 2023-07-07 5:00 pm Purchase | 2022-11-22 | 13D | NewAmsterdam Pharma Company N.V. NAMS | ForDyne B.V. | 8,242,400 10.100% | 8,242,400 (New Position) | Filing |